Categoría: Heart Disease
-
Business is Booming as Pfizer Targets the Aging Processs With New Adult Stem Cell Research
As yet another indication of the economic maturation of an industry, the pharmaceutical giant Pfizer is now developing anti-aging stem cell products.
-
An Adult Stem Cell Company Wins Award for Innovation
The biotech company Mesoblast Ltd., specializing in regenerative medicine, is awarded a prestigious award for its adult stem cell technology.
-
Pfizer Expands Into Stem Cell Research
Lured by the promise of financial profit, the pharmaceutical giant Pfizer joins the stem cell community.
-
Two Leading Biotech Companies Collaborate on a Department of Defense Contract for Adult Stem Cell Applications in Warfare
In an effort to develop adult stem cell therapies that are specifically targeted to counteracting the biological dangers of nuclear warfare, the U.S. Deparment of Defense has awarded a $224.7 million contract to an Osiris-Genzyme partnership.
-
FDA Authorizes Device for Bone Marrow Stem Cell Preparation
A leading manufacturer of medical machinery that is used in the processing of stem cells has received FDA approval for the marketing of its newest device.
-
Large-Scale Adult Stem Cell Trials Planned for Children With Sickle Cell Anemia
Researchers at the Washington University School of Medicine in St. Louis lead a nationwide, multicenter clinical trial to study the efficacy of adult stem cell therapy in the treatment of children with sickle cell anemia.
-
Researchers Report First Successful Creation of Heart Tissue From Adult Heart Stem Cells
Scientists in the Netherlands are the first to isolate stem cells from the adult human heart, from which they were then able to grow new heart tissue.
-
Stem Cells From Menstrual Blood Offer New Hope in Organ Transplantation and in the Treatment of Numerous Diseases
Stromal cells found in menstrual blood offer a highly preferable alternative therapy to a number of diseases including those requiring organ transplantation.
-
Heart Treatment with iPS Cells – Joint Japanese Research
Two scientists from Japan will use iPS cells to research treatment for heart damage.